Souhaitez-vous accéder aux communiqués récents ?

Photocure will present its first quarter report on Tuesday 10 May 2016 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will be...

Oslo, Norway, May 2, 2016: Photocure ASA announced today the American Urological Association (AUA) and the Society of Urological Oncology (SUO) have included enhanced cystoscopy in the 2016...

Oslo, Norway, 28 April, 2016. The Annual General Meeting in Photocure ASA took place on 28 April, 2016. A new Board of Directors was elected and consists of the following members until next...

Oslo, 27 April 2016: Photocure ASA (OSE: PHO). Reference is made to the stock exchange release disclosed 26 April 2016, regarding proxies received by Bente-Lill Bjerkelund Romøren in connection...

 Oslo, 26 April 2016: Photocure ASA (OSE: PHO). Bente-Lill Bjerkelund Romøren has as chairperson of the board of directors of PHO received proxies to vote for 1,288,250 shares at the annual general...

Photocure ASA Oslo, Norway, 26th April 2016: Photocure ASA (OSE: PHO), is pleased to announce publication of a new analysis demonstrating that Blue Light Cystoscopy (BLC) with Hexvix/Cysview...

  This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. ...

Oslo, 6 April 2016: Photocure ASA (OSE: PHO), has published the annual accounts and annual report for the financial year 2015. The annual accounts and annual report for the financial year 2015 are...

Oslo, 6 April 2016: Photocure ASA (OSE: PHO), calls for the annual general meeting of PHO to be held at Hoffsveien 4, 1st floor, 0275 Oslo, Norway on 28 April 2016 at 17:00 hours (CET). The notice...

Oslo, 15 March 2016 - Photocure (OSE: PHO), a specialty pharmaceutical company with focus on photodynamic technologies in cancer and dermatology today announces that a new patent for Cevira has been...